Roivant Sciences Stock Analysis

Roivant Stock Analysis Notes

About 30.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Roivant Sciences recorded a loss per share of 0.75. The entity had not issued any dividends in recent years. Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people. To find out more about Roivant Sciences contact Matthew Gline at 44 20 7400 3347 or learn more at https://roivant.com.

Roivant Sciences Investment Alerts

Roivant Sciences Upcoming and Recent Events

Roivant Largest EPS Surprises

View All Earnings Estimates

Roivant Sciences Environmental, Social, and Governance (ESG) Scores

Roivant Stock Institutional Investors

Note, although Roivant Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Roivant Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.78 B.

Roivant Profitablity

Management Efficiency

Roivant Sciences has return on total asset (ROA) of (0.1073) % which means that it has lost $0.1073 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1254) %, meaning that it created substantial loss on money invested by shareholders. Roivant Sciences' management efficiency ratios could be used to measure how well Roivant Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.03 in 2025. Return On Capital Employed is likely to drop to -0.2 in 2025. At this time, Roivant Sciences' Net Tangible Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 443.1 M in 2025, whereas Other Current Assets are likely to drop slightly above 83.5 M in 2025.

Technical Drivers

As of the 19th of July, Roivant Sciences holds the Semi Deviation of 1.66, coefficient of variation of 1009.17, and Risk Adjusted Performance of 0.0978. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Roivant Sciences, as well as the relationship between them. Please check Roivant Sciences coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Roivant Sciences is priced some-what accurately, providing market reflects its current price of 11.44 per share. Given that Roivant Sciences has jensen alpha of 0.0756, we recommend you to check out Roivant Sciences's recent market performance to make sure the company can sustain itself at a future point.

Roivant Sciences Price Movement Analysis

Roivant Sciences Insider Trading Activities

Roivant Sciences Outstanding Bonds

Roivant Sciences Predictive Daily Indicators

Roivant Sciences Corporate Filings

Roivant Sciences Forecast Models

Roivant Sciences' time-series forecasting models are one of many Roivant Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Roivant Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Roivant Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Roivant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Roivant Sciences. By using and applying Roivant Stock analysis, traders can create a robust methodology for identifying Roivant entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Roivant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Roivant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Roivant Sciences stock analysis indicators help investors evaluate how Roivant Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Roivant Sciences shares will generate the highest return on investment. By understating and applying Roivant Sciences stock analysis, traders can identify Roivant Sciences position entry and exit signals to maximize returns.

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.